Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 66-70

  Preston, R A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Division of Clinical Pharmacology   (United States)

Author keywords

ALDOSTERONE; DROSPIRENONE; HORMONE REPLACEMENT; HYPERTENSION; MENOPAUSE

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DROSPIRENONE PLUS ESTRADIOL; ENALAPRIL MALEATE; ESTROGEN; HYDROCHLOROTHIAZIDE; MEDROXYPROGESTERONE ACETATE; PLACEBO; ALDOSTERONE ANTAGONIST; ANDROSTANE DERIVATIVE; ANTIHYPERTENSIVE AGENT; DROSPIRENONE;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DRUG ACTIVITY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ALDOSTERONE ANTAGONISTS; ANDROSTENES; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; HYPERTENSION; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 73949108428     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902775788     Document Type: Article

References (16)

1. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the perimenopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007;28:2028-40 (Pubitemid 47579557)
2. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536
3. Mosca L, Appel LJ, Benjamin EJ, et al. Evidencebased guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 2004;43:900-21 (Pubitemid 38296494)
4. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on cardiovascular disease. N Engl J Med 2001;345:1291-7
5. Mueck AO, Seeger H. Effect of hormone therapy on blood pressure in normotensive and hypertensive postmenopausal women. Maturitas 2004;49:189-203 (Pubitemid 39370786)
6. Karalis I, Beevers DG, Beevers M, Lip GYH. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. Blood Pressure 2005;14:38-44 (Pubitemid 40443752)
7. Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
9. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12
10. Nair GV, Chaput LA, Vittinghoff E, Herrington DM. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease. Chest 2005;127:1498-506 (Pubitemid 46218772)
11. Ashraf MS, Vongpatanasin W. Estrogen and blood pressure. Curr Hypertens Rep 2006;8:368-76
12. Archer DF, Thorneycroft IH, Foegh M, et al. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause 2005;12:716-27 (Pubitemid 41669124)
13. White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17-beta-estradiol, a novel hormone treatment in post-menopausal women with stage 1 hypertension. Circulation 2005;112:1979-84 (Pubitemid 41377417)
14. Preston RA, Alonso A, Panzitta D, Zhang P, Karara AH. Additive effect of drospirenone/17-beta estradiol in hypertensive postmenopausal women receiving enalapril. Am J Hypertens 2002;15:816-22 (Pubitemid 34970112)
15. Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 2005;18:797-804 (Pubitemid 40745265)
16. Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Randomized, placebo-controlled, trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007;14:408-14